Cytosorbents Corp (CTSO) Profit Margins
Over the twelve months to 2026-06-30, Cytosorbents Corp (CTSO) had gross margin 71.6%, operating margin -34.7%, net margin -48.9%, free cash flow margin -25.0%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CTSOCytosorbents CorpFollow CTSO — free
—
Price chart with a free account
- Market cap
- 16.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 76.2% | 21.1% | 48.2% | 53.8% | 58.5% | 63.6% | 66.7% | 70.5% | 73.0% | 74.4% | 59.8% | 70.6% | 69.9% | 71.5% | 71.6% | |
| Operating margin | -259.9% | -194.5% | -167.2% | -194.2% | -120.6% | -65.0% | -69.3% | -76.0% | -25.3% | -52.7% | -90.9% | -102.8% | -46.2% | -39.8% | -34.7% | |
| Net margin | -272.8% | -193.1% | -226.1% | -197.8% | -123.5% | -55.8% | -76.5% | -77.2% | -19.1% | -56.9% | -94.6% | -94.1% | -58.2% | -22.1% | -48.9% | |
| FCF margin | -270.8% | -145.6% | -165.3% | -197.2% | -72.1% | -49.2% | -51.2% | -70.0% | -15.4% | -40.9% | -98.9% | -71.4% | -41.3% | -33.8% | -25.0% |
USD millions · SEC XBRL
Cytosorbents Corp — questions
- What is Cytosorbents Corp's gross margin?
- 71.6% over the twelve months to 2026-06-30.
- What is Cytosorbents Corp's operating margin?
- -34.7% over the twelve months to 2026-06-30.
- What is Cytosorbents Corp's net profit margin?
- -48.9% over the twelve months to 2026-06-30.
Every figure on this page comes from Cytosorbents Corp's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.